A
Aurisco Pharmaceutical Co Ltd
SSE:605116
Aurisco Pharmaceutical Co Ltd
SSE:605116
Price:
23.59 CNY
1.03%
Market Closed
Updated:
May 21, 2024
Aurisco Pharmaceutical Co Ltd
Interest Income Expense
|
Aurisco Pharmaceutical Co Ltd
Interest Income Expense Peer Comparison
Comparables:
C
1093
H
3692
600436
600276
000538
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
A
|
Aurisco Pharmaceutical Co Ltd
SSE:605116
|
Interest Income Expense
¥27.1m
|
CAGR 3-Years
79%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
C
|
CSPC Pharmaceutical Group Ltd
HKEX:1093
|
Interest Income Expense
¥71.6m
|
CAGR 3-Years
-48%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Interest Income Expense
¥1.1B
|
CAGR 3-Years
52%
|
CAGR 5-Years
82%
|
CAGR 10-Years
N/A
|
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Interest Income Expense
¥134.5m
|
CAGR 3-Years
7%
|
CAGR 5-Years
4%
|
CAGR 10-Years
23%
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Interest Income Expense
¥429.9m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
30%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Interest Income Expense
¥1.1B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
37%
|
See Also
What is Aurisco Pharmaceutical Co Ltd's Interest Income Expense?
Interest Income Expense
27.1m
CNY
27.1m
CNY
Based on the financial report for Dec 31, 2022, Aurisco Pharmaceutical Co Ltd's Interest Income Expense amounts to 27.1m CNY.
What is Aurisco Pharmaceutical Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 3Y
79%
79%
Over the last year, the Interest Income Expense growth was 1 694%. The average annual Interest Income Expense growth rates for Aurisco Pharmaceutical Co Ltd have been 79% over the past three years .
You don't have any saved screeners yet
